Article
Genomics of Alzheimer's disease: Value of high-throughput genomic technologies to dissect its etiology.
Molecular and cellular probes - 1 Dec 2016
Tosto Giuseppe, Reitz Christiane
Abstract excerpt
Late-onset Alzheimer's disease (AD), the most common neurodegenerative disorder in western countries, is clinically defined by progressive worsening in cognitive functions along with function and behavioral impairment. This ultimately results in complete incapacity and death. AD is a clinically and pathologically heterogeneous disease, and this is reflected by the numerous genetic findings that point to several...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
